Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Medi Caps Ltd Performance

Today's Low
49.00
arrowIcon
Today's High
51.60
52 Wk Low
36.01
arrowIcon
52 Wk High
63.49


Open

51.6

Traded Value (Cr)

26.70 K

Prev. Close

49.28

VWAP

50.03

Volume

534.00

Face Value

10

Medi Caps Ltd Fundamentals

Market Cap
₹ 62 Cr
P/E Ratio (TTM)
0.00
P/B Ratio
0.52
Debt to Equity
0.00
ROE
-1.65 %
EPS (TTM)
0.00
Dividend Yield
0.00%
Book Value
96.11

Click here to know more about Fundamentals

Medi Caps Ltd Financials

Medi Caps Ltd Financials

Medi Caps Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 50.13 % 50.13 % 50.13 % 50.13 %
Retail 44.83 % 44.59 % 44.41 % 44.74 %
Others 5.03 % 5.27 % 5.45 % 5.12 %
Mutual Funds 0.01 % 0.01 % 0.01 % 0.01 %
FII 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

50.13%

Retail

44.83%

Others

5.03%

Mutual Funds

0.01%

FII

0.00%

Promoters

50.13%

Retail

44.59%

Others

5.27%

Mutual Funds

0.01%

FII

0.00%

Promoters

50.13%

Retail

44.41%

Others

5.45%

Mutual Funds

0.01%

FII

0.00%

Promoters

50.13%

Retail

44.74%

Others

5.12%

Mutual Funds

0.01%

FII

0.00%

Resistance and Support

₹50.92

PIVOT

resistance-arrow
Resistance
First Resistance₹52.787
Second Resistance₹55.853
Third Resistance₹57.717
support-arrow
Support
First Resistance₹47.857
Second Resistance₹45.993
Third Resistance₹42.927
RSI34.568
MACD-0.343
ADX9.451
CCI-149.849

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day4,2423,41580.50
Week7,1295,77378.50
1 Month8,1106,91180.79
6 Months000.00

About Medi Caps Ltd

Medi-caps was incorporated by S L Mittal in Aug.'83 as a private limited company and was converted into a public limited company in Mar.'86. Pharmaceutical companies procure empty hard gelatine capsules from Medi-caps for dosaged medicines meant for oral administration. The company is the second-largest manufacturer of empty hard gelatine capsules in India. It takes several years for a company manufacturing capsules to attain zero-defect in production and to fully normalise operations. Medi-caps can claim to have achieved this. In Apr.'95, the company offered 6.11 lac rights shares at a premium of Rs 116 to part-finance the Rs 9.19-cr expansion of its manufacturing facilities (from 2000 mln pa to 3440 mln pa) by installing four high-speed automatic capsule-making machines. The company's manufacturing unit is located in Pithampur, Madhya Pradesh. The company's clientele include US Vitamins, SOL Pharmaceuticals, Dr Reddy's Laboratories, Lupin Laboratories, Aristo Pharmaceuticals, etc. At present, it has 40 clients. The other group company of Medi-caps is Medi-caps Finance which is engaged in finance related activities. In 1993, R C Mittal received the Glory of India International award. In 1995-96, the company enhanced the capacity of empty hard gelatine capsules by 2500 lac. The company received ISO 9002 Certification during 1998-99. It developed six sizes of the Hard Gelatin Capsules in 2002-03. The company is closely working on commissioning of 13th Machine with 100% automisation. During 2002-03 the company established the export market in countries like China,Thailand,Dubai,Malaysia,South Africa and Philipines. The Company permanently discontinued its manufacturing activities on 21.11.2019 at the plant in Pithampur, Dhar Dist. and ventured into Real Estate Business and in continuation of this, it executed an agreement with the Tirupati Reality & Developers on 12 October, 2020 for Project named Medicaps Business Park.

Managing Director

Alok K Garg

Founded

1983

NSE Symbol

MEDICAPS

Medi Caps Ltd Management

NameDesignation
R C MittalChairman (Non-Executive)
Alok K GargManaging Director
Pramod FatehpuriaNon-Exec. & Independent Dir.
Ashok Omprakash AgrawalNon-Exec. & Independent Dir.
Kusum MittalNon Executive Director
Dharmendra SolankiIndependent Director
Abhishek KumarCompany Sec. & Compli. Officer
Gajendra SinghIndependent Director

Medi Caps Ltd News

Medi Caps reports consolidated net loss of Rs 0.16 crore in the December 2023 quarter
Sales decline 36.69% to Rs 6.92 crore
Medi Caps to announce Quarterly Result
On 8 February 2024
Medi Caps consolidated net profit declines 94.39% in the September 2023 quarter
Sales decline 60.82% to Rs 5.99 crore
Medi Caps announces board meeting date
On 8 November 2023
Medi Caps to conduct AGM
On 29 September 2023
Medi Caps reports consolidated net loss of Rs 1.11 crore in the June 2023 quarter
Sales decline 48.73% to Rs 6.24 crore
Medi Caps schedules board meeting
On 11 August 2023
Medi Caps consolidated net profit declines 76.00% in the March 2023 quarter
Sales decline 38.64% to Rs 10.18 crore
Medi Caps to convene board meeting
On 23 May 2023
Medi Caps reports consolidated net loss of Rs 1.34 crore in the December 2022 quarter
Sales decline 36.86% to Rs 10.93 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
DLF₹ 2,07,208 Cr
₹ 835.90
(-0.14 %)
111.76
GODREJPROP₹ 76,640 Cr
₹ 2,752.65
(-0.14 %)
135.79
PRESTIGE₹ 59,628 Cr
₹ 1,465.00
(-1.51 %)
265.63
OBEROIRLTY₹ 53,122 Cr
₹ 1,475.00
(0.96 %)
85.19
PHOENIXLTD₹ 50,466 Cr
₹ 2,815.10
(-0.32 %)
176.61

Medi Caps Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Medi Caps Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Medi Caps Ltd's share price is ₹50.00 as of May 10, 2024

Medi Caps Ltd's P/E ratio is 0.00 times as of May 10, 2024.

Medi Caps Ltd's most recent financial reports indicate a price-to-book ratio of 0.52, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Medi Caps Ltd's market is 62 Cr as on May 10, 2024.

The current financial records of Medi Caps Ltd show a -1.65% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Medi Caps Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Medi Caps Ltd's 52-week high and low as of May 10, 2024 are ₹51.6 and ₹49 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Medi Caps Ltd stands at 50.13%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.